Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash flows from operating activities:
Net (loss) income	$ (527)	$ 572
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	182	202
Accretion of financing instruments and other non-cash interest	52	52
Impairment charge on investment in iBio, Inc.	251
Change in deferred tax assets, net	247
Stock based compensation	8	26
Change in fair value of derivative liabilities	(67)	731
Gain on sale of fixed assets	(3)
Changes in operating assets and liabilities:
Accounts receivable	(575)	(1,285)
Inventories	(413)	(70)
Other current assets	(1)	33
Security deposits and other assets	(19)	(71)
Accounts payable	1,379	166
Accrued expenses and other liabilities	126	191
Net cash provided by operating activities	640	547
Cash flows from investing activities:
Purchase of property and equipment	(210)	(83)
Cash proceeds from sale of equipment	4
Net cash used in investing activities	(206)	(83)
Cash flows from financing activities:
Advances under revolving credit facility	19,673	23,040
Proceeds from sales/lease back of equipment	143
Repayments of advances under revolving credit facility	(19,559)	(23,246)
Repayments under term note payables	(669)	(515)
Repayments under capitalized lease obligations	(100)	(72)
Net cash used in financing activities	(512)	(793)
Net decrease in cash	(78)	(329)
Cash at beginning of period	132	395
Cash at end of period	54	66
Supplemental disclosures of cash flow information:
Interest	394	472
Income taxes	$ 109	$ 227